By Allison Lea
On July 1, the Federation of American Societies for Experimental Biology (FASEB) welcomed the Society for Free Radical Biology and Medicine (SFRBM) as its 27th member society. SFRBM’s application for membership was approved by the FASEB Board earlier last month.
Founded in 1987, SFRBM is an international organization of scientists, investigators, and clinicians who conduct research in the area of redox biology, as well as oxidants and antioxidants. These areas have shown explosive growth over the last decade and are now integral to major initiatives in basic, applied, and translational research, including the development of therapies for cancer, heart disease, aging, and cardiovascular disease. SFRBM fosters a balanced approach to understanding both the advantageous and deleterious properties of free radicals, active oxygen species, and related oxidants and reductants.
SFRBM Immediate Past President Harry Ischiropoulos, PhD, will represent the Society on FASEB’s Board of Directors. Dr. Ischiropoulos is a Research Professor at the University of Pennsylvania Perelman School Of Medicine in Philadelphia and is affiliated with the Children’s Hospital of Philadelphia Research Institute.
“SFRBM is a dynamic and rapidly growing association in an important area of biomedical research. We are proud to welcome them to the Federation and look forward to working with the Society and its membership as we address the challenges before us,” stated FASEB President Joseph R. Haywood, PhD. “This is a critical time, and we all need to marshal our resources to continue our progress in science and advocacy for science.”